Stephan Stern

Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice: I. Enhancement of acetaminophen nephrotoxicity by acetaminophen-cysteine.

Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity II. Possible involvement of the gamma-glutamyl cycle.

An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity.

Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma.

Gender-related differences in mycophenolate mofetil-induced gastrointestinal toxicity in rats.

Nanotechnology safety concerns revisited.

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.

Androgen regulation of renal uridine diphosphoglucuronosyltransferase 1A1 in rats.

Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?

Role for nanomaterial-autophagy interaction in neurodegenerative disease.

Electrically induced tilt in achiral bent-core liquid crystals.

Detoxification of gold nanorods by treatment with polystyrenesulfonate.

Translational considerations for cancer nanomedicine.

Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.

A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.

Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction.

Evaluation of cytotoxicity of nanoparticulate materials in porcine kidney cells and human hepatocarcinoma cells.

Monitoring nanoparticle-treated hepatocarcinoma cells for apoptosis.

Detecting reactive oxygen species in primary hepatocytes treated with nanoparticles.

Assay to detect lipid peroxidation upon exposure to nanoparticles.

Monitoring glutathione homeostasis in nanoparticle-treated hepatocytes.

Autophagy monitoring assay: qualitative analysis of MAP LC3-I to II conversion by immunoblot.

Monitoring lysosomal activity in nanoparticle-treated cells.

Femtosecond X-ray protein nanocrystallography.

Single mimivirus particles intercepted and imaged with an X-ray laser.

Lipidic phase membrane protein serial femtosecond crystallography.

In vivo protein crystallization opens new routes in structural biology.

Time-resolved protein nanocrystallography using an X-ray free-electron laser.

Femtosecond free-electron laser x-ray diffraction data sets for algorithm development.

Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity.

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.

Guidelines for the use and interpretation of assays for monitoring autophagy.

Pattern-stabilized decorated polar liquid-crystal fibers.

Transitions between paraelectric and ferroelectric phases of bent-core smectic liquid crystals in the bulk and in thin freely suspended films.

Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.

Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models.

Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretion.

A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.

PLGA/Liposome Hybrid Nanoparticles for Short-Chain Ceramide Delivery.

Self-terminating diffraction gates femtosecond X-ray nanocrystallography measurements.

Radiation damage in protein serial femtosecond crystallography using an x-ray free-electron laser.